Development of [F-18]afatinib as new TKI-PET tracer for EGFR positive tumors

P. Slobbe; A.D. Windhorst; M. Stigter-van Walsum; R.C. Schuit; E.F. Smit; H.G. Niessen; F. Solca; G Stehle; G.A.M.S. van Dongen; A.J. Poot

doi:https://doi.org/10.1016/j.nucmedbio.2014.06.005

Development of [F-18]afatinib as new TKI-PET tracer for EGFR positive tumors

P. Slobbe, A.D. Windhorst, M. Stigter-van Walsum, R.C. Schuit, E.F. Smit, H.G. Niessen, F. Solca, G Stehle, G.A.M.S. van Dongen, A.J. Poot

Research output: Contribution to journal › Article › Academic › peer-review

39 Citations (Scopus)

Original language	Undefined/Unknown
Pages (from-to)	749-757
Journal	Nuclear medicine and biology
Volume	41
Issue number	9
DOIs	https://doi.org/10.1016/j.nucmedbio.2014.06.005
Publication status	Published - 2014

Access to Document

https://doi.org/10.1016/j.nucmedbio.2014.06.005

Cite this

@article{93722744d3e6449cb1e39057d1821d54,

title = "Development of [F-18]afatinib as new TKI-PET tracer for EGFR positive tumors",

author = "P. Slobbe and A.D. Windhorst and {Stigter-van Walsum}, M. and R.C. Schuit and E.F. Smit and H.G. Niessen and F. Solca and G Stehle and {van Dongen}, G.A.M.S. and A.J. Poot",

year = "2014",

doi = "https://doi.org/10.1016/j.nucmedbio.2014.06.005",

language = "Undefined/Unknown",

volume = "41",

pages = "749--757",

journal = "Nuclear medicine and biology",

issn = "0969-8051",

publisher = "Elsevier Inc.",

number = "9",

}

TY - JOUR

T1 - Development of [F-18]afatinib as new TKI-PET tracer for EGFR positive tumors

AU - Slobbe, P.

AU - Windhorst, A.D.

AU - Stigter-van Walsum, M.

AU - Schuit, R.C.

AU - Smit, E.F.

AU - Niessen, H.G.

AU - Solca, F.

AU - Stehle, G

AU - van Dongen, G.A.M.S.

AU - Poot, A.J.

PY - 2014

Y1 - 2014

U2 - https://doi.org/10.1016/j.nucmedbio.2014.06.005

DO - https://doi.org/10.1016/j.nucmedbio.2014.06.005

M3 - Article

C2 - 25066021

SN - 0969-8051

VL - 41

SP - 749

EP - 757

JO - Nuclear medicine and biology

JF - Nuclear medicine and biology

IS - 9

ER -